Skip to main content

Find Clinical Trials

Home
Conditions
Influenza, Human

Clinical trial condition

Influenza, Human

Explore clinical trials studying Influenza, Human. Study availability and eligibility vary by location and protocol.

1,849 public trials 84 recruiting studies

Refine in advanced search Browse all conditions

Influenza, Human trial results

Completed

Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate

NCT00385840

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Elverum, Norway

GSK Investigational Site Hamar, Norway

GSK Investigational Site Paradis, Norway

GSK Investigational Site Stavanger, Norway

View Trial Details

Completed

Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

NCT00538473

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate

NCT00321763

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Tartu, Estonia

GSK Investigational Site Caen, France

GSK Investigational Site Gières, France

GSK Investigational Site Lagord, France

View all 46 locations

View Trial Details

Completed

Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults.

NCT00714285

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Hradec Králové, Czechia

View Trial Details

Completed

A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza

NCT02603952

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Research Site Canoga Park, California, United States

Research Site Long Beach, California, United States

Research Site Los Angeles, California, United States

Research Site Upland, California, United States

View all 31 locations

View Trial Details

Completed

Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate

NCT00374842

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Wilrijk, Belgium

View Trial Details

Completed

Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix

NCT00693706

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Miami, Florida, United States

GSK Investigational Site Lenexa, Kansas, United States

View Trial Details

Completed

Immunogenicity and Safety Study of Allantoic Split Inactivated Seasonal Influenza Vaccine (VSI)

NCT03016143

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Kazakh National Medical University Almaty, Kazakhstan

View Trial Details

Completed

B-cell Immunity to Influenza (SLVP017)- Year 1, 2009

NCT02133781

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Stanford LPCH Vaccine Program Stanford, California, United States

View Trial Details

Completed

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children

NCT02207413

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Wichita, Kansas, United States

GSK Investigational Site Rochester, New York, United States

GSK Investigational Site Warwick, Rhode Island, United States

GSK Investigational Site Nashville, Tennessee, United States

View all 53 locations

View Trial Details